# Nationwide Laboratories, LLC – FDA Inspection, Nov 27, 2018

Source: https://www.keypedia.com/records/fda_inspections/nationwide-laboratories-llc/ef042152-39ba-4172-bae5-ecaa352e26f7
Source feed: FDA_Inspections

> FDA inspection 1072711 of Nationwide Laboratories, LLC, November 27, 2018. Classification: Official Action Indicated (OAI). 3 citations under 21 CFR parts 211 and 310. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1072711
- Company Name: Nationwide Laboratories, LLC
- Inspection Date: 2018-11-27
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 988951 - 2016-08-19](https://www.keypedia.com/records/fda_inspections/nationwide-laboratories-llc/34624d0c-efa1-4b92-b10f-0a531a5cc8b2)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/helen-verdel/f6caf5a8-74f5-4833-bd00-5579b369f4f9)
- [Company Rep](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)

Company: https://www.keypedia.com/companies/nationwide-laboratories-llc/e5dccf31-f7a6-4a51-9f59-7e2929127933

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c